MIDATECH PHARMA
About Us | Strategy

Midatech’s strategy is to expand its US commercial presence as well as develop its platform technologies into multiple products in order to achieve multiple potential revenue opportunities. Its business model has three key components:

Its commercialisation strategy is to build an enduring, profitable and commercially focused enterprise with revenues generated as follows:

In oncology, Midatech has the opportunity to leverage its own commercial capabilities in the US and roll out similar infrastructure in Europe around the market entry of its orphan oncology program products.

About Us
Strategy

Midatech’s strategy is to expand its US commercial presence as well as develop its platform technologies into multiple products in order to achieve multiple potential revenue opportunities. Its business model has three key components:

Its commercialisation strategy is to build an enduring, profitable and commercially focused enterprise with revenues generated as follows:

In oncology, Midatech has the opportunity to leverage its own commercial capabilities in the US and roll out similar infrastructure in Europe around the market entry of its orphan oncology program products.

© Copyright 2017 Midatech Pharma PLC